NEW YORK (GenomeWeb) – By using the CRISPR/Cas9 genome editing approach, researchers from the University of California, San Francisco report that they were able to correct β-thalassemia gene mutations in patient-specific iPS cells.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.
GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.
In Science this week: self-assembly of DNA components in solution, and more.
Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.